Antimicrobial susceptibilities and ESBL production rates of Salmonella and Shigella strains in Turkey

被引：12

作者：

Kiliç, D ^{[1
]}

Tulek, N ^{[1
]}

Tuncer, G ^{[1
]}

Doganci, L ^{[1
]}

Willke, A ^{[1
]}

机构：

[1] Kirikkale Univ, Sch Med, Infect Dis & Clin Bacteriol Dept, Besevler, Turkey

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2001年 / 7卷 / 06期

关键词：

D O I：

10.1046/j.1198-743x.2001.00261.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：341 / 342

页数：2

共 14 条

[1]

[Anonymous], MORB MORTAL WKLY REP

[2] IN-VITRO ACTIVITY OF 8 ANTIBIOTICS AGAINST SALMONELLA AND SHIGELLA SPECIES [J].

ARMAN, D ;

WILLKE, A ;

TURAL, D .

EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1994, 10 (03) :345-347

[3]

BAUERNFEIND A, 1992, INFECTION, V20, P48

[4] CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia [J].

Bradford, PA ;

Yang, YJ ;

Sahm, D ;

Grope, I ;

Gardovska, D ;

Storch, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1980-1984

[5]

Ceyhan M, 1996, J DIARRHOEAL DIS RES, V14, P187

[6]

Doganci L, 1997, PEDIATR INFECT DIS J, V16, P1096

[7] Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis [J].

Gaillot, O ;

Clement, C ;

Simonet, M ;

Philippon, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (01) :85-87

[8]

MANDELL GL, 2000, PRINCIPLES PRACTICE, P2363

[9] NEW EXTENDED-SPECTRUM TEM-TYPE BETA-LACTAMASE FROM SALMONELLA-ENTERICA SUBSP ENTERICA ISOLATED IN A NOSOCOMIAL OUTBREAK [J].

MOROSINI, MI ;

CANTON, R ;

MARTINEZBELTRAN, J ;

NEGRI, MC ;

PEREZDIAZ, JC ;

BAQUERO, F ;

BLAZQUEZ, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :458-461

[10]

*NCCLS, 1998, PERF STAND ANT DISK, V18, pM2

← 1 2 →